D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Liberty Media Series C
FWONK
|
+$422M |
| 2 |
Alibaba
BABA
|
+$360M |
| 3 |
HP
HPQ
|
+$296M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Gilead Sciences
GILD
|
+$242M |
Top Sells
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
AbbVie
ABBV
|
+$324M |
| 3 |
Liberty Media Series A
FWONA
|
+$314M |
| 4 |
GE Aerospace
GE
|
+$229M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| 1 | Technology | 13.85% |
| 2 | Consumer Discretionary | 12.91% |
| 3 | Energy | 12.08% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Silicon Laboratories
SLAB
$4.45B
| $3.28M | ﹤0.01% |
80,738
-143,644
| -64% | -$5.84M |
|
1002
Belden
BDC
$5.29B
| $3.27M | ﹤0.01% |
51,052
+30,553
| +149% | +$1.96M |
|
1003
Comcast
CMCSA
$123B
| $3.27M | ﹤0.01% |
121,400
-218,814
| -64% | -$5.88M |
|
|
EQY
1004
DELISTED
Equity One
EQY
| $3.26M | ﹤0.01% |
+150,744
| New | +$3.26M |
|
1005
First Horizon
FHN
$11.6B
| $3.26M | ﹤0.01% |
265,478
-186,994
| -41% | -$2.3M |
|
|
NUAN
1006
DELISTED
Nuance Communications, Inc.
NUAN
| $3.25M | ﹤0.01% |
243,676
-449,325
| -65% | -$6M |
|
1007
O'Reilly Automotive
ORLY
$91.5B
| $3.25M | ﹤0.01% |
323,670
-93,450
| -22% | -$937K |
|
|
MIC
1008
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.25M | ﹤0.01% |
48,649
+31,078
| +177% | +$2.07M |
|
|
MGI
1009
DELISTED
MoneyGram International, Inc. New
MGI
| $3.23M | ﹤0.01% |
257,635
+106,940
| +71% | +$1.34M |
|
1010
Exelon
EXC
$44B
| $3.23M | ﹤0.01% |
132,705
-495,855
| -79% | -$12.1M |
|
1011
TTEC Holdings
TTEC
$179M
| $3.21M | ﹤0.01% |
130,609
-38,013
| -23% | -$935K |
|
|
RIOM
1012
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
| $3.19M | ﹤0.01% |
1,338,833
+1,322,633
| +8,164% | +$3.15M |
|
1013
W.P. Carey
WPC
$15B
| $3.18M | ﹤0.01% |
50,859
+6,804
| +15% | +$425K |
|
1014
Scully Royalty
SRL
$81.5M
| $3.17M | ﹤0.01% |
89,187
+17,759
| +25% | +$631K |
|
1015
Bio-Rad Laboratories Class A
BIO
$7.74B
| $3.17M | ﹤0.01% |
27,947
+12,196
| +77% | +$1.38M |
|
|
WG
1016
DELISTED
Willbros Group
WG
| $3.17M | ﹤0.01% |
380,383
+700
| +0.2% | +$5.83K |
|
|
EV
1017
DELISTED
Eaton Vance Corp.
EV
| $3.17M | ﹤0.01% |
+83,951
| New | +$3.17M |
|
|
DMND
1018
DELISTED
DIAMOND FOODS, INC.
DMND
| $3.15M | ﹤0.01% |
110,138
+39,520
| +56% | +$1.13M |
|
|
WW
1019
DELISTED
WW International
WW
| $3.14M | ﹤0.01% |
114,579
-239,744
| -68% | -$6.58M |
|
|
BAGL
1020
DELISTED
EINSTEIN NOAH RESTAURANT GROUP, INC CMN STK (DELAWARE)
BAGL
| $3.14M | ﹤0.01% |
155,934
+39,468
| +34% | +$796K |
|
1021
Chunghwa Telecom
CHT
$34.9B
| $3.14M | ﹤0.01% |
104,643
-59,372
| -36% | -$1.78M |
|
1022
Dynavax Technologies
DVAX
$1.14B
| $3.12M | ﹤0.01% |
218,371
-5,683
| -3% | -$81.3K |
|
1023
Rogers Communications
RCI
$19.4B
| $3.12M | ﹤0.01% |
+83,400
| New | +$3.12M |
|
1024
Medtronic
MDT
$121B
| $3.12M | ﹤0.01% |
+50,375
| New | +$3.12M |
|
|
SSRI
1025
DELISTED
Silver Standard Resources
SSRI
| $3.12M | ﹤0.01% |
511,705
-13,593
| -3% | -$82.9K |
|